Jeff Ajer joined BioMarin in August 2005 and currently serves as our Chief Commercial Officer. From October 2012 to January 2014, Jeff served as Senior Vice President and Chief Commercial Officer. From April 2009 to October 2012, he served as our Vice President, Commercial Operations, the Americas, where he had responsibility for commercial operations throughout the Americas and led product marketing, reimbursement and sales operations for BioMarin.

Prior to joining BioMarin, Jeff served in various roles at Genzyme Corp. beginning in November 2003, most recently as Vice President, Global Transplant Operations from December 2004 to August 2005. His experience prior to Genzyme includes roles in sales, marketing and operations at SangStat Medical Corp. and ICN Pharmaceuticals.

Jeff holds a B.S. in chemistry and an M.B.A., both from the University of California, Irvine. Mr. Ajer is currently a director of Nektar Therapeutics, a public biopharmaceutical company.